Swiss Investment in US Surges Amid Lingering Trade Threats

Swiss businesses have significantly boosted their investment in the United States, pouring $27 billion into the US economy in the first four months of the year. This substantial financial commitment is a direct response to a deal struck with Washington last November, which stipulated a $200 billion investment pledge from the Swiss private sector over five years.

The agreement was a strategic move by Switzerland to mitigate punitive US tariffs. After facing the threat of 39% import duties, Switzerland secured a reduction to 15% by agreeing to the large-scale investment plan. This has already begun to show results, with major Swiss corporations, particularly in the pharmaceutical industry, actively developing new projects in the US.

Novartis, for instance, is expanding its research center in San Diego as part of this initiative. However, the economic relationship between Bern and Washington is far from stable. Despite these considerable investments, Swiss companies continue to face the looming threat of new US customs measures, casting a shadow over the future of bilateral economic ties.